Basel Medical Group (NASDAQ:BMGL) Issues Earnings Results

Posted by Shane Hupp on Jun 28th, 2026

Basel Medical Group (NASDAQ:BMGL – Get Free Report) issued its earnings results on Friday, June 26th. The company reported $0.01 earnings per share (EPS) for the quarter, reports. The company had revenue of $3.21 million during the quarter.

Basel Medical Group Stock Performance

Shares of NASDAQ:BMGL opened at $6.62 on Friday. The firm’s 50 day simple moving average is $7.39 and its two-hundred day simple moving average is $7.60. The company has a quick ratio of 1.83, a current ratio of 1.88 and a debt-to-equity ratio of 0.93. Basel Medical Group has a 1-year low of $4.60 and a 1-year high of $54.60.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of BMGL. Marex Group plc bought a new position in shares of Basel Medical Group in the second quarter worth about $25,000. Virtu Financial LLC lifted its holdings in Basel Medical Group by 108.8% in the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after purchasing an additional 17,608 shares in the last quarter. Finally, Citadel Advisors LLC bought a new position in Basel Medical Group in the 3rd quarter worth approximately $169,000.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut Basel Medical Group from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, June 30th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Get Our Latest Stock Analysis on BMGL

Basel Medical Group Company Profile

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.